A tool to help doctors discuss Alzheimer's blood tests with patients
Tests a tool guiding primary care doctors in talking with patients about Alzheimer's blood tests.
Plain-language title generated from the registry record
Registry title: Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care
Key facts
- Where
- Madison, United StatesSee the site
Where in United States
- School of Medicine and Public Health, University of WisconsinMadison, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Wisconsin, Madison
- Trial code
- NCT07812337
- Record updated
- 28 October 2026
- Original description
The goal of the current study is to evaluate a decision-support tool intended to help primary care providers (PCPs) communicate with patients about blood biomarker testing for Alzheimer's Disease, enhancing shared-decision making and information sharing in the clinical space. The main questions it aims to answer are:Read full original descriptionShow less
Pilot Evaluation of a Tool to Support Communication About Blood Biomarker Testing for Cognitive Complaints in Primary Care
The goal of the current study is to evaluate a decision-support tool intended to help primary care providers (PCPs) communicate with patients about blood biomarker testing for Alzheimer's Disease, enhancing shared-decision making and information sharing in the clinical space. The main questions it aims to answer are:
* Is the decision-support tool accepted and easy to use for PCPs? * Does using the tool improve shared decision-making during clinical encounters? Researchers will compare clinical encounters between PCPs who do not use the tool to discuss blood biomarker testing for Alzheimer's Disease, versus PCPs who have been trained to utilize the tool during clinical encounters to see whether the tool effectively facilitates shared-decision making.
Inclusion: Simulation 1 and Simulation 2: PCPs with experience and interest in cognitive diagnosis; Simulation 2: community dwelling older adults age 50 or older are eligible.
Exclusion: pre-existing diagnosis of cognitive impairment; age <50 years; Participant Exclusion Criteria:; Not fluent in English; having an activated medical decision-make r or not living independently in the community; There will be no exclusion based upon sex/gender, race, or ethnicity.